Hanibuchi M - Search Results

1

E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.

Ikuta K, Yano S, Trung VT, Hanibuchi M, Goto H, Li Q, Wang W, Yamada T, Ogino H, Kakiuchi S, Uehara H, Sekido Y, Uenaka T, Nishioka Y, Sone S. Ikuta K, et al. Among authors: hanibuchi m. Clin Cancer Res. 2009 Dec 1;15(23):7229-37. doi: 10.1158/1078-0432.CCR-09-1980. Epub 2009 Nov 24. Clin Cancer Res. 2009. PMID: 19934291

2

Influence of systemic chemotherapy on anti-P-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.

Nabioullin R, Yanagawa H, Haku T, Hiramatsu K, Yano S, Hanibuchi M, Pai K, Tsuruo T, Sone S. Nabioullin R, et al. Among authors: hanibuchi m. Jpn J Clin Oncol. 1995 Aug;25(4):124-30. Jpn J Clin Oncol. 1995. PMID: 7666588

3

Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.

Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Sone S. Hanibuchi M, et al. Jpn J Cancer Res. 1996 May;87(5):497-504. doi: 10.1111/j.1349-7006.1996.tb00251.x. Jpn J Cancer Res. 1996. PMID: 8641987 Free PMC article.

4

Systemic chemotherapy alters interleukin-1 beta and its receptor antagonist production by human alveolar macrophages in lung cancer patients.

Haku T, Yanagawa H, Ohmoto Y, Takeuchi E, Yano S, Hanibuchi M, Nokihara H, Nishimura N, Sone S. Haku T, et al. Among authors: hanibuchi m. Oncol Res. 1996;8(12):519-26. Oncol Res. 1996. PMID: 9160356

5

Intrapleural instillation of interferon gamma in patients with malignant pleurisy due to lung cancer.

Yanagawa H, Haku T, Hiramatsu K, Nokihara H, Takeuchi E, Yano S, Hanibuchi M, Sone S. Yanagawa H, et al. Among authors: hanibuchi m. Cancer Immunol Immunother. 1997 Oct;45(2):93-9. doi: 10.1007/s002620050407. Cancer Immunol Immunother. 1997. PMID: 9390200 Free PMC article.

6

Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice.

Yano S, Nokihara H, Hanibuchi M, Parajuli P, Shinohara T, Kawano T, Sone S. Yano S, et al. Among authors: hanibuchi m. Oncol Res. 1997;9(11-12):573-9. Oncol Res. 1997. PMID: 9563004

7

The role of cyclosporin A on antibody-dependent monocyte-mediated cytotoxicity against human multidrug-resistant cancer cells.

Yano S, Yanagawa H, Hanibuchi M, Pai K, Nishioka Y, Tsuruo T, Sone S. Yano S, et al. Among authors: hanibuchi m. J Med Invest. 1998 Feb;44(3-4):185-91. J Med Invest. 1998. PMID: 9597807

8

Effect of clarythromycin on the distant metastases of human lung cancer cells in SCID mice.

Parajuli P, Yano S, Hanibuchi M, Nokihara H, Shinohara T, Sone S. Parajuli P, et al. Among authors: hanibuchi m. J Med Invest. 1998 Feb;44(3-4):205-10. J Med Invest. 1998. PMID: 9597810

9

Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.

Shrivastava P, Hanibuchi M, Yano S, Parajuli P, Tsuruo T, Sone S. Shrivastava P, et al. Among authors: hanibuchi m. Cancer Chemother Pharmacol. 1998;42(6):483-90. doi: 10.1007/s002800050849. Cancer Chemother Pharmacol. 1998. PMID: 9788575

10

Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice.

Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Kawano T, Sone S. Hanibuchi M, et al. Int J Cancer. 1998 Nov 9;78(4):480-5. doi: 10.1002/(sici)1097-0215(19981109)78:4<480::aid-ijc14>3.0.co;2-a. Int J Cancer. 1998. PMID: 9797137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters